Vertex cleans up its pipeline; FDA grants priority review to Jakafi for GVHD
→ While AbbVie was stepping up to challenge Vertex on cystic fibrosis today, the Boston-based biotech was engaged in a little pipeline cleanup. Vertex …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
